The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review

SAGE Open Medicine

Volumn 4, Issue , 2016, Pages

  Riordan, David O ^a   Walsh, Kieran A ^a   Galvin, Rose ^b   Sinnott, Carol ^a   Kearney, Patricia M ^a   Byrne, Stephen ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Older people; Pharmacist interventions; Prescribing; Primary care; Systematic review

Indexed keywords

ADULT; ANTICOAGULATION; CLINICAL OUTCOME; DIABETES MELLITUS; DRUG DOSE REDUCTION; DYSLIPIDEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; PHARMACIST; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; STRENGTH; SYSTEMATIC REVIEW;

EID: 84994480861     PISSN: None     EISSN: 20503121     Source Type: Journal    
DOI: 10.1177/2050312116652568     Document Type: Review

References (44)

1. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013-1019.
2. Jano E and Aparasu RR. Healthcare outcomes associated with Beers’ criteria: a systematic review. Ann Pharmacother 2007; 41: 438-447.
3. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173-184.
4. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832.
5. O’Sullivan D, Byrne S and O’Mahony D. An evaluation of the inappropriate prescribing in older residents in long term care facilities in the greater Cork and Northern Ireland regions using the STOPP and Beers’ criteria. Centre for Ageing Research and Development in Ireland (CARDI), 2011.
6. Cahir C, Fahey T, Teeling M, et al. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010; 69: 543-552.
7. Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012; 68: 1425-1433.
8. Bradley MC, Motterlini N, Padmanabhan S, et al. Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr 2014; 14: 72.
9. Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004; 164: 1621-1625.
10. Marriott J and Stehlik P. A critical analysis of the methods used to develop explicit clinical criteria for use in older people. Age Ageing 2012; 41: 441-450.
11. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
12. Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009; 68: 936-947.
13. Galvin R, Moriarty F, Cousins G, et al. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol 2014; 70: 599-606.
14. Hanlon JT and Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging 2013; 30: 893-900.
15. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004; 38: 9-14.
16. Muijrers PE, Knottnerus JA, Sijbrandij J, et al. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci 2003; 25: 235-241.
17. Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014; 10: 1-119.
18. Castelino RL, Bajorek BV and Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009; 43: 1096-1106.
19. Alldred DP, Kennedy MC, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev 2016; 2: CD009095.
20. Walsh KA, O’Riordan D, Kearney PM, et al. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age Ageing 2016; 45: 201-209.
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
22. Shade MY, Berger AM and Chaperon C. Potentially inappropriate medications in community-dwelling older adults. Res Gerontol Nurs 2014; 7: 178-192.
23. Cochrane Collaboration. Suggested risk of bias criteria for EPOC reviews.1-4.
24. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: 1-9.
25. Bryant LJM, Coster G, Gamble GD, et al. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract 2011; 19: 94-105.
26. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428-437.
27. Taylor CT, Byrd DC and Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003; 60: 1123-1129.
28. Richmond S, Morton V, Cross B, et al. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract 2010; 60: 10-19.
29. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc 2007; 55: 977-985.
30. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
31. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-1536.
32. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823-2829.
33. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997; 31: 529-533.
34. Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010; 44: 957-963.
35. Hanlon JT, Sloane RJ, Pieper CF, et al. Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age Ageing 2011; 40: 274-277.
36. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26: 1013-1028.
37. Topinkova E, Baeyens JP, Michel JP, et al. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012; 29: 477-494.
38. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012; 379: 1310-1319.
39. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394-401.
40. Hartung DM, Hamer A, Middleton L, et al. A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics. BMC Fam Pract 2012; 13: 129.
41. Maltais R, Schmidt T, Chhina H, et al. Academic detailing to optimize care for RA by family physicians - results of a satisfaction survey. J Rheumatol 2014; 41: 1494-1495.
42. Van Hoof TJHL, Miller NE, Pappas MS, et al. Characteristics of academic detailing: results from a systematic review. Am Health Drug Benefits 2015; 8: 414-442.
43. Lowrie R, Lloyd SM, McConnachie A, et al. A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care. PLoS ONE 2014; 9: e113370.
44. Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998; 18: 327-332.